In order to further dissect the role of COX-2 in the pathophysiology of CAVD, we performed correlation analyses between COX-2 expression levels and clinical, laboratory, and echocardiographic parameters in CAVD patients (Supplementary Table S1). This evidence concerns the gene PTGS2 and congenital bilateral aplasia of vas deferens from CFTR mutation.